These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Pharma 2020--An Economist Conference Shaping the Future of the Pharmaceuticals Industry. Kibble A IDrugs; 2008 May; 11(5):331-3. PubMed ID: 18465672 [No Abstract] [Full Text] [Related]
24. The value of medicines in Canada. Han D; Wang EC Can J Clin Pharmacol; 2005; 12(1):e10-21. PubMed ID: 16055940 [TBL] [Abstract][Full Text] [Related]
25. Medicare & drugs: the elusive prize revisited. Iglehart JK Health Aff (Millwood); 2000; 19(2):6-7. PubMed ID: 10718017 [No Abstract] [Full Text] [Related]
27. Should the practice of drug sampling be retained or eliminated? Hosp Formul; 1994 Nov; 29(11):780, 782. PubMed ID: 10138575 [No Abstract] [Full Text] [Related]
28. The cost and value of new medicines in an era of change. Proceedings of a symposium at the Tufts University European Center. Talloires, France. July 25-27, 2001. Pharmacoeconomics; 2002; 20 Suppl 3():vii-xi; 1-108. PubMed ID: 12542026 [No Abstract] [Full Text] [Related]
29. The right pill for growth. The high cost of developing blockbuster drugs forces big makers into bigger mergers. Fischer JS US News World Rep; 1999 Nov; 127(19):56. PubMed ID: 10623304 [No Abstract] [Full Text] [Related]
30. Medicare should bargain for lower drug prices, study says. Med Health; 2005 Oct; 59(36):1, 3, 7. PubMed ID: 16240494 [No Abstract] [Full Text] [Related]
31. Drug costs can be defended. Lee AM Med Mark Media; 1982 Mar; 17(3):36, 38, 40 passim. PubMed ID: 10309584 [No Abstract] [Full Text] [Related]
32. Are rich nations up for drug reform? Check E Nature; 2006 May; 441(7090):135. PubMed ID: 16688137 [No Abstract] [Full Text] [Related]
34. Counting the true cost and value of medicines. Ingram RA Oncologist; 2003; 8(1):2-4. PubMed ID: 12604727 [No Abstract] [Full Text] [Related]
35. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada. Openshaw MS Nurs Econ; 2005; 23(6):307-11, 279. PubMed ID: 16459902 [TBL] [Abstract][Full Text] [Related]
36. [Drug development costs are overstated by the industry]. Jeppsson A Lakartidningen; 2006 Mar 1-7; 103(9):663-4; discussion 664. PubMed ID: 16583545 [No Abstract] [Full Text] [Related]
37. [Economic or medical innovations: that is the question!]. Freitag MH; Wohlgemuth WA Med Klin (Munich); 2006 Jul; 101(7):590-1; author reply 591-3. PubMed ID: 16897896 [No Abstract] [Full Text] [Related]
38. American Society of Clinical Oncology guidance statement: the cost of cancer care. Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE; J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533 [TBL] [Abstract][Full Text] [Related]
39. FDA chief wants other rich countries to share drug development costs. Hopkins Tanne J BMJ; 2003 Oct; 327(7419):830. PubMed ID: 14551076 [No Abstract] [Full Text] [Related]
40. It's time to look at Rx pricing. Why study reimporting Canadian drugs when the real issue is U.S. prices? Sloane T Mod Healthc; 2004 Mar; 34(11):18. PubMed ID: 15069795 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]